Registered Nurse in Burlington, IA Accepting Medicare
7 Registered Nurse nurses found. Showing 1 - 7
 Kelly S Rankin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 407 N 4th St, Burlington, IA 52601 Phone: 319-754-4618 Fax: 319-754-4193 |
Ms. Gloria Gene Mcmillan, PMHNP-BC Registered Nurse - Psych/Mental Health, Adult Medicare: Medicare Enrolled Practice Location: 400 S Broadway St, Burlington, IA 52601 Phone: 319-768-5858 Fax: 319-671-7030 |
Denise Reichman, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2509 Sunrise Ln, Burlington, IA 52601 Phone: 319-601-9987 |
Martha Lutenegger, RN Registered Nurse - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 407 N 4th St, Burlington, IA 52601 Phone: 319-754-4618 Fax: 319-754-4193 |
Amber Nichole Roethlisberger, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1212 Indian Hills Dr, Burlington, IA 52601 Phone: 319-752-1200 |
Trinity Jasmine Barton, RN, CLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 920 Osborn St, Burlington, IA 52601 Phone: 319-214-3379 |
Sileen Ann Pringle, MSN ARNP ANPC GNP BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2700 Mount Pleasant St Ste 32b, Burlington, IA 52601 Phone: 319-752-8234 Fax: 319-752-8244 |
News Archive
Phylogenetic network analysis reveals recombinant origin of the SARS-CoV-2 alpha (B.1.1.7) variant
Researchers from the U.S. recently used the phylogenetic network approach to analyze the origin of the VOC202012/01 (alpha) or the PANGO Lineage B.1.1.7 variant, which was first reported in U.K. in 2020 and soon spread to other countries. This study is published on the bioRxiv preprint server while the paper undergoes peer review.
Novel gene replacement therapy holds promise for Spinal Muscular Atrophy
Children who suffer from the devastating disease Spinal Muscular Atrophy are set to benefit from a new breakthrough in therapy developments by researchers at the University of Sheffield.
Researchers develop a novel probiotic formulation with high anti-SARS-CoV-2 potency
A team of international scientists recently conducted a randomized clinical trial to assess the safety and efficacy profiles of a novel probiotic formulation in symptomatic coronavirus disease 2019 (COVID-19) patients. The findings indicate that the probiotic formulation is highly effective in reducing symptom severity in COVID-19 patients without causing any adverse events.
3M launches new Rapid Detection Respiratory Syncytial Virus Test
Expanding its platform of rapid diagnostic testing, 3M today announced the introduction of the 3M™ Rapid Detection RSV Test. RSV, or respiratory syncytial virus, is a respiratory virus that infects the lungs and breathing passages and is a common cause of bronchitis and pneumonia in children under one year.
New findings could help develop treatments for inherited disorders
Fresh insights into the protective seal that surrounds the DNA of our cells could help develop treatments for inherited muscle, brain, bone and skin disorders.
› Verified 9 days ago